EP. 1: Episode 2 - Diverse Applications Amidst a Growing Pipeline
Watch
EP. 2: Episode 1 - The Advent of Cancer Immunotherapy: Addressing Unmet Needs
EP. 3: Episode 3 - Managed Care Concerns and Treatment Accessibility
EP. 4: Episode 4 - Pushing Reform through Immunotherapy
EP. 5: Episode 5 - Recent Additions to the Pipeline
EP. 6: Episode 6 - Recommended Guidelines and Payer Challenges
EP. 7: Episode 7 - Immunotherapy: Where Is It At? Where Is It Headed?
EP. 8: Episode 8 - A Managed Care Approach to Immunotherapy
EP. 9: Episode 9 - The Payer Approach to Immunotherapy
EP. 10: Episode 10 - Measuring Economic Burden or Value Against Clinical Outcomes
EP. 11: Epsiode 11 - The Impact of Combination Therapies on Resource Allocations
EP. 12: Epsiode 12 - Healthcare Reform's Impact on Immunotherapy (Part 1)
EP. 13: Episode 13 - Healthcare Reform's Impact on Immunotherapy (Part 2)
EP. 14: Episode 14 - Conclusion: Final Thoughts Concerning Immunotherapy